Market Price

15.83 

-0.63 -3.8%

as of Feb 25 '21

52 Week Range:

2.19 17.20


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to meet the surgeon's needs and to maximize patient outcomes; LLICO access system, a minimally invasive posterior thoracolumbar access system; Invictus Spinal Fixation System, a comprehensive thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep designed to improve surgical efficiency without compromising accuracy. It also provides Arsenal spinal fixation system intended for posterior, non-cervical fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, fracture or dislocation, spinal stenosis, curvatures, tumor, pseud arthrosis, and failed previous fusion; zodiac degenerative spinal fixation system, a comprehensive spinal system used to address degenerative spinal conditions and deformity correction; OsseoScrew system to restore the integrity of the spinal column; trestle luxe anterior cervical plate system; and solanas posterior cervico/thoracic fixation system and avalon occipital plate. In addition, the company offers IdentiTi Porous Ti and Transcend Lateral Interbody Implants; Battalion PC; Novel SD; Solus Anterior Lumbar Interbody Fusion System. Further, it is developing EOS imaging products. Additionally, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 17.09
35.91
35.92
30.51
28.15
18.43
-3.07
-4.22
-1.69
0.56
0.93
growth rate 110.1% 0.0% -15.1% -7.7% -34.5% -100.0% 0.0% 0.0% 100.0% 66.1%
Earnings BIT -13.05
-16.49
-26.69
-16.62
-79.05
7.99
-5.32
-10.85
-7.35
-23.03
-57.14
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0%
Avg.PE -12.20
-21.90
-10.60
-10.70
-1.33
-1.33
-1.33
-1.33
-2.14
-2.14
-2.14
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ROA -8.37
-5.33
-5.97
-4.13
-21.99
-4.35
-72.69
-24.85
-2.57
-39.66
-38.07
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ROE -18.17
-8.41
-8.67
-6.30
-39.39
-9.64
-317.99
-186.27
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ROIC -10.79
-4.54
-6.89
-3.53
-30.99
-2.89
-124.19
-69.96
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cur. Ratio 1.78
2.82
2.04
2.15
1.43
1.78
0.81
1.81
2.24
2.47
2.98
growth rate 58.4% -27.7% 5.4% -33.5% 24.5% -54.5% 123.5% 23.8% 10.3% 20.7%
Quick Ratio 0.92
1.44
1.09
1.11
0.79
0.95
0.40
0.95
1.25
1.45
1.74
growth rate 56.5% -24.3% 1.8% -28.8% 20.3% -57.9% 137.5% 31.6% 16.0% 20.0%
Leverage 2.16
1.42
1.49
1.55
2.13
2.32
7.37
3.90
growth rate -34.3% 4.9% 4.0% 37.4% 8.9% 33.5% -47.1%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 24.80
39.80
42.96
44.00
42.77
40.44
26.87
18.51
14.82
15.45
16.15
growth rate 60.5% 7.9% 2.4% -2.8% -5.4% -33.6% -31.1% -19.9% 4.2% 4.6%
Acct.Payable 49.97
53.73
73.79
10.13
13.54
8.70
3.88
26.72
34.19
growth rate 7.5% 37.3% -86.3% 33.7% -35.8% -55.4% 588.9% 28.0%
Cur.Assets 67.60
122.80
116.43
122.05
113.75
113.11
101.50
72.82
66.48
75.54
108.32
growth rate 81.7% -5.2% 4.8% -6.8% -0.6% -10.3% -28.3% -8.7% 13.6% 43.4%
Total Assets 161.90
377.00
366.69
382.13
365.63
344.92
146.34
94.19
84.66
129.48
169.95
growth rate 132.9% -2.7% 4.2% -4.3% -5.7% -57.6% -35.6% -10.1% 52.9% 31.3%
Cash 10.10
23.20
20.67
22.24
21.35
19.74
6.30
19.59
22.47
29.05
47.11
growth rate 129.7% -10.9% 7.6% -4.0% -7.5% -68.1% 211.3% 14.7% 29.3% 62.2%
Inventory 29.50
51.60
45.92
49.86
41.94
41.75
32.63
30.09
27.29
28.77
34.85
growth rate 74.9% -11.0% 8.6% -15.9% -0.5% -21.8% -7.8% -9.3% 5.4% 21.2%
Cur.Liabilities 38.10
43.60
57.14
56.79
79.72
63.60
125.04
40.14
29.74
30.61
36.39
growth rate 14.4% 31.1% -0.6% 40.4% -20.2% 96.6% -67.9% -25.9% 2.9% 18.9%
Liabilities 87.10
110.60
97.76
112.71
170.35
172.37
159.31
112.09
87.72
88.30
101.79
growth rate 27.0% -11.6% 15.3% 51.1% 1.2% -7.6% -29.6% -21.8% 0.7% 15.3%
LT Debt 23.60
32.50
23.80
39.97
49.98
74.60
0.48
43.09
37.77
42.30
53.45
growth rate 37.7% -26.8% 67.9% 25.1% 49.3% -99.4% 8,877.5% -12.4% 12.0% 26.4%
Equity 74.80
266.40
245.33
245.82
171.68
148.95
-36.58
-41.50
-26.66
17.57
43.63
growth rate 256.2% -7.9% 0.2% -30.2% -13.2% -100.0% 0.0% 0.0% 100.0% 148.3%
Common Shares 4.00
7.00
7.00
8.00
8.00
8.00
8.00
9.00
13.00
43.37
61.40
growth rate 75.0% 0.0% 14.3% 0.0% 0.0% 0.0% 12.5% 44.4% 233.6% 41.6%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 11.80
14.00
8.21
15.65
14.35
11.30
12.25
8.90
7.60
6.51
13.03
growth rate 18.6% -41.4% 90.7% -8.3% -21.3% 8.4% -27.4% -14.6% -14.2% 100.1%
Cash Dividends 0.00
0.50
0.00
0.00
0.00
growth rate -100.0%
Cash From OA -5.55
-14.83
13.41
11.59
7.81
-20.27
10.12
-9.96
-8.73
-25.61
-33.12
growth rate 0.0% 100.0% -13.5% -32.7% -100.0% 100.0% -100.0% 0.0% 0.0% 0.0%
FCF per Share -4.56
-4.76
-0.44
-0.77
-1.35
-3.74
-0.81
-0.75
-2.52
-0.72
-0.98
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock 0.10
0.08
0.01
0.03
0.38
0.11
24.39
51.90
55.83
growth rate -26.9% -89.5% 262.5% 1,193.1% -69.6% 21,291.2% 112.8% 7.6%
FCF -19.00
-31.00
5.00
-6.00
-7.00
-32.00
-2.00
-19.00
-16.00
-33.00
-46.00
growth rate 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 120.60
171.60
197.71
196.28
204.72
154.63
134.39
120.25
101.74
91.69
113.43
growth rate 42.3% 15.2% -0.7% 4.3% -24.5% -13.1% -10.5% -15.4% -9.9% 23.7%
Op.Income -10.20
-11.80
-22.18
-15.46
-82.23
7.99
-5.32
-10.85
-7.35
-22.44
-47.28
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0%
IBT -13.40
-16.50
-26.69
-16.62
-79.05
0.31
-172.40
-30.94
-4.57
-30.17
-57.14
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0%
Net Income -13.30
-14.40
-22.18
-15.46
-82.23
-12.88
-178.68
-29.93
-2.29
-28.98
-57.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -3.24
-2.16
-3.00
-2.04
-10.20
-1.90
-21.53
-3.49
-1.08
-1.20
-1.09
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Gross Profit 81.00
112.80
116.93
123.77
124.32
110.87
93.42
76.63
68.22
63.24
77.59
growth rate 39.3% 3.7% 5.9% 0.5% -10.8% -15.7% -18.0% -11.0% -7.3% 22.7%
R&D 19.90
19.40
16.89
14.89
14.19
16.59
17.62
9.25
4.92
9.98
13.85
growth rate -2.5% -13.0% -11.9% -4.7% 16.9% 6.2% -47.5% -46.8% 102.9% 38.7%

Quarterly Statements

Item Name Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Earnings BIT -8.23
-3.78
-20.68
-7.17
-8.21
growth rate 0.0% 0.0% 0.0% 0.0%
Balance Sheet Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Acct.Receivable 15.63
16.15
15.38
20.36
25.20
growth rate 3.3% -4.8% 32.4% 23.8%
Acct.Payable 28.98
34.19
35.57
40.59
44.89
growth rate 18.0% 4.1% 14.1% 10.6%
Cur.Assets 117.40
108.32
91.71
95.96
86.68
growth rate -7.7% -15.3% 4.6% -9.7%
Total Assets 178.28
169.95
153.84
161.14
154.68
growth rate -4.7% -9.5% 4.7% -4.0%
Cash 57.84
47.11
27.47
31.16
15.68
growth rate -18.6% -41.7% 13.5% -49.7%
Inventory 33.07
34.85
37.87
41.47
42.14
growth rate 5.4% 8.7% 9.5% 1.6%
Cur.Liabilities 31.59
36.39
38.24
42.80
48.17
growth rate 15.2% 5.1% 11.9% 12.6%
Liabilities 95.76
101.79
102.25
118.52
122.97
growth rate 6.3% 0.5% 15.9% 3.8%
LT Debt 51.09
53.45
53.03
66.07
65.76
growth rate 4.6% -0.8% 24.6% -0.5%
Equity 57.65
43.63
27.43
18.82
8.05
growth rate -24.3% -37.1% -31.4% -57.2%
Common Shares 60.67
61.40
63.26
63.85
64.56
growth rate 1.2% 3.0% 0.9% 1.1%
Cash Flow Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Capital Expenditures 6.72
2.60
2.63
4.35
5.89
growth rate -61.4% 1.3% 65.4% 35.4%
Cash Dividends
growth rate
Cash From OA -9.41
-9.07
-17.05
-13.10
-9.54
growth rate 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock 54.65
-0.22
0.83
0.55
-0.18
growth rate -100.0% 100.0% -34.5% -100.0%
FCF -16.13
-11.66
-19.68
-17.45
-15.43
growth rate 0.0% 0.0% 0.0% 0.0%
Income Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Sales 29.20
32.35
30.12
29.63
41.16
growth rate 10.8% -6.9% -1.6% 38.9%
Op.Income -11.60
-14.50
-17.81
-11.16
-12.86
growth rate 0.0% 0.0% 0.0% 0.0%
IBT -14.52
-17.40
-20.68
-15.75
-15.63
growth rate 0.0% 0.0% 0.0% 0.0%
Net Income -14.57
-17.03
-20.72
-15.81
-15.67
growth rate 0.0% 0.0% 0.0% 0.0%
EPS
growth rate
Gross Profit 19.93
22.21
21.03
20.84
29.24
growth rate 11.4% -5.3% -0.9% 40.3%
R&D 3.96
3.06
3.75
3.67
4.38
growth rate -22.8% 22.6% -2.1% 19.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (0.00)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE -2.14 -14.42 -21.97
EPS / Growth 0.0% -1.10 12.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 34.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.0% 15.4% 15.4%
Future PE 0.00 0.01 10.26
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.